Fig. 3
From: Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Mechanisms driving tumor cell plasticity and drug resistance. Both tumor microenvironment factors and EMT-related signaling pathways regulate the EMT process. The activation of EMT facilitates the dedifferentiation of non-cancer stem cells (CSCs) to CSC, which contributies to tumor heterogeneity
